Which has preferable valuation & earnings, PRE or WALD?

Prenetics Global has higher earnings, but lower revenue than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Prenetics Global $92.39M 3.99 -$37.71M -$4.16 N/A Waldencast $272.07M 0.00 -$229.75M N/A N/A

Do analysts recommend USNA or WALD?

Waldencast has a consensus price target of $2.33, suggesting a potential upside of 0.00%. Given Waldencast's stronger consensus rating and higher possible upside, analysts plainly believe Waldencast is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Waldencast 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger valuation & earnings, USNA or WALD?

USANA Health Sciences has higher revenue and earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio USANA Health Sciences $925.26M 0.29 $10.76M -$1.21 N/A Waldencast $272.07M 0.00 -$229.75M N/A N/A

Do analysts recommend WALD or YSG?

Waldencast presently has a consensus target price of $2.33, indicating a potential upside of 0.00%. Given Waldencast's stronger consensus rating and higher probable upside, equities analysts clearly believe Waldencast is more favorable than Yatsen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waldencast 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Yatsen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, WALD or YSG?

Yatsen has higher revenue and earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.00 -$229.75M N/A N/A Yatsen $614.62M 0.39 -$11.56M -$0.32 N/A

Is WALD or YSG more profitable?

Waldencast has a net margin of 0.00% compared to Yatsen's net margin of -4.63%. Waldencast's return on equity of 0.00% beat Yatsen's return on equity. Company Net Margins Return on Equity Return on Assets Waldencast N/A N/A N/A Yatsen -4.63% -7.26% -5.42%

Do analysts recommend WALD or NUS?

Waldencast currently has a consensus price target of $2.33, indicating a potential upside of 0.00%. Given Waldencast's stronger consensus rating and higher possible upside, equities research analysts plainly believe Waldencast is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waldencast 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Nu Skin Enterprises 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, WALD or NUS?

Nu Skin Enterprises has higher revenue and earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.00 -$229.75M N/A N/A Nu Skin Enterprises $1.49B 0.16 $160.20M -$4.47 N/A

Which has better earnings & valuation, WALD or NATR?

Nature's Sunshine Products has higher revenue and earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.00 -$229.75M N/A N/A Nature's Sunshine Products $480.14M 0.46 $19.52M $1.01 12.51

Waldencast (WALD) Competitors

Compare

WALD vs. PRE, USNA, YSG, NUS, and NATR

Should you buy Waldencast stock or one of its competitors? Waldencast's main competitors and comparable companies include Prenetics Global (PRE), USANA Health Sciences (USNA), Yatsen (YSG), Nu Skin Enterprises (NUS), and Nature's Sunshine Products (NATR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Waldencast compare to Prenetics Global?

Prenetics Global (NASDAQ:PRE) and Waldencast (NASDAQ:WALD) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 42.0% of Waldencast shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Prenetics Global currently has a consensus target price of $35.67, indicating a potential upside of 63.31%. Waldencast has a consensus target price of $2.33, indicating a potential upside of 0.00%. Given Prenetics Global's stronger consensus rating and higher possible upside, equities research analysts plainly believe Prenetics Global is more favorable than Waldencast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Waldencast has a net margin of 0.00% compared to Prenetics Global's net margin of -47.43%. Waldencast's return on equity of 0.00% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-47.43%	-21.41%	-15.56%
Waldencast	N/A	N/A	N/A

In the previous week, Prenetics Global and Prenetics Global both had 1 articles in the media. Waldencast's average media sentiment score of 1.82 beat Prenetics Global's score of 1.49 indicating that Waldencast is being referred to more favorably in the news media.

Company	Overall Sentiment
Prenetics Global	Positive
Waldencast	Very Positive

Prenetics Global has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, Waldencast has a beta of -0.1, meaning that its share price is 110% less volatile than the broader market.

Prenetics Global has higher earnings, but lower revenue than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	3.99	-$37.71M	-$4.16	N/A
Waldencast	$272.07M	0.00	-$229.75M	N/A	N/A

Summary

Prenetics Global and Waldencast tied by winning 6 of the 12 factors compared between the two stocks.

How does Waldencast compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Waldencast (NASDAQ:WALD) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

USANA Health Sciences has higher revenue and earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.29	$10.76M	-$1.21	N/A
Waldencast	$272.07M	0.00	-$229.75M	N/A	N/A

Waldencast has a consensus price target of $2.33, suggesting a potential upside of 0.00%. Given Waldencast's stronger consensus rating and higher possible upside, analysts plainly believe Waldencast is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, USANA Health Sciences had 6 more articles in the media than Waldencast. MarketBeat recorded 7 mentions for USANA Health Sciences and 1 mentions for Waldencast. Waldencast's average media sentiment score of 1.82 beat USANA Health Sciences' score of 0.34 indicating that Waldencast is being referred to more favorably in the news media.

Company	Overall Sentiment
USANA Health Sciences	Neutral
Waldencast	Very Positive

Waldencast has a net margin of 0.00% compared to USANA Health Sciences' net margin of -2.43%. USANA Health Sciences' return on equity of 3.41% beat Waldencast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Waldencast	N/A	N/A	N/A

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 42.0% of Waldencast shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

USANA Health Sciences has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market. Comparatively, Waldencast has a beta of -0.1, meaning that its stock price is 110% less volatile than the broader market.

Summary

USANA Health Sciences beats Waldencast on 8 of the 13 factors compared between the two stocks.

How does Waldencast compare to Yatsen?

Waldencast (NASDAQ:WALD) and Yatsen (NYSE:YSG) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Waldencast presently has a consensus target price of $2.33, indicating a potential upside of 0.00%. Given Waldencast's stronger consensus rating and higher probable upside, equities analysts clearly believe Waldencast is more favorable than Yatsen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Yatsen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Waldencast has a beta of -0.1, meaning that its share price is 110% less volatile than the broader market. Comparatively, Yatsen has a beta of -1.71, meaning that its share price is 271% less volatile than the broader market.

In the previous week, Waldencast had 1 more articles in the media than Yatsen. MarketBeat recorded 1 mentions for Waldencast and 0 mentions for Yatsen. Waldencast's average media sentiment score of 1.82 beat Yatsen's score of 0.00 indicating that Waldencast is being referred to more favorably in the media.

Company	Overall Sentiment
Waldencast	Very Positive
Yatsen	Neutral

Waldencast has a net margin of 0.00% compared to Yatsen's net margin of -4.63%. Waldencast's return on equity of 0.00% beat Yatsen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
Yatsen	-4.63%	-7.26%	-5.42%

Yatsen has higher revenue and earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.00	-$229.75M	N/A	N/A
Yatsen	$614.62M	0.39	-$11.56M	-$0.32	N/A

42.0% of Waldencast shares are held by institutional investors. 29.0% of Yatsen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Waldencast beats Yatsen on 10 of the 13 factors compared between the two stocks.

How does Waldencast compare to Nu Skin Enterprises?

Waldencast (NASDAQ:WALD) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

Nu Skin Enterprises has higher revenue and earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.00	-$229.75M	N/A	N/A
Nu Skin Enterprises	$1.49B	0.16	$160.20M	-$4.47	N/A

Waldencast has a beta of -0.1, indicating that its share price is 110% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market.

In the previous week, Waldencast had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 1 mentions for Waldencast and 0 mentions for Nu Skin Enterprises. Waldencast's average media sentiment score of 1.82 beat Nu Skin Enterprises' score of 0.25 indicating that Waldencast is being referred to more favorably in the media.

Company	Overall Sentiment
Waldencast	Very Positive
Nu Skin Enterprises	Neutral

Waldencast has a net margin of 0.00% compared to Nu Skin Enterprises' net margin of -15.73%. Nu Skin Enterprises' return on equity of 6.58% beat Waldencast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
Nu Skin Enterprises	-15.73%	6.58%	3.63%

Waldencast currently has a consensus price target of $2.33, indicating a potential upside of 0.00%. Given Waldencast's stronger consensus rating and higher possible upside, equities research analysts plainly believe Waldencast is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Nu Skin Enterprises	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

42.0% of Waldencast shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Nu Skin Enterprises beats Waldencast on 7 of the 13 factors compared between the two stocks.

How does Waldencast compare to Nature's Sunshine Products?

Waldencast (NASDAQ:WALD) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

42.0% of Waldencast shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 3.1% of Nature's Sunshine Products shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Nature's Sunshine Products had 2 more articles in the media than Waldencast. MarketBeat recorded 3 mentions for Nature's Sunshine Products and 1 mentions for Waldencast. Waldencast's average media sentiment score of 1.82 beat Nature's Sunshine Products' score of 1.63 indicating that Waldencast is being referred to more favorably in the media.

Company	Overall Sentiment
Waldencast	Very Positive
Nature's Sunshine Products	Very Positive

Waldencast has a beta of -0.1, indicating that its stock price is 110% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

Waldencast currently has a consensus target price of $2.33, suggesting a potential upside of 0.00%. Nature's Sunshine Products has a consensus target price of $30.50, suggesting a potential upside of 141.30%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than Waldencast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Nature's Sunshine Products	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Nature's Sunshine Products has a net margin of 3.68% compared to Waldencast's net margin of 0.00%. Nature's Sunshine Products' return on equity of 12.88% beat Waldencast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
Nature's Sunshine Products	3.68%	12.88%	8.17%

Nature's Sunshine Products has higher revenue and earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.00	-$229.75M	N/A	N/A
Nature's Sunshine Products	$480.14M	0.46	$19.52M	$1.01	12.51

Summary

Nature's Sunshine Products beats Waldencast on 11 of the 12 factors compared between the two stocks.

Get Waldencast News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WALD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WALD vs. The Competition

Export

Metric	Waldencast	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$111.75M	$23.18B	$15.89B	$13.29B
Dividend Yield	N/A	5.53%	3.31%	22.58%
P/E Ratio	N/A	20.27	12.44	20.21
Price / Sales	N/A	12.88	264,976.43	87.84
Price / Cash	13.72	16.88	56.37	36.12
Price / Book	N/A	2.89	4.34	6.16
Net Income	-$229.75M	$1.13B	$844.17M	$381.12M
7 Day Performance	-1.18%	1.21%	0.85%	-1.40%
1 Month Performance	-33.66%	-4.71%	-2.58%	-3.35%
1 Year Performance	-53.28%	-19.53%	9.74%	1.49%

Waldencast Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WALD Waldencast	3.2654 of 5 stars	N/A	$2.33 +∞	-53.3%	$111.75M	$272.07M	N/A	367	Positive News Gap Up
PRE Prenetics Global	4.5437 of 5 stars	$21.93 -0.3%	$35.67 +62.7%	+57.2%	$369.88M	$92.39M	N/A	98	Positive News
USNA USANA Health Sciences	1.3411 of 5 stars	$14.53 -0.9%	N/A	-27.7%	$268.64M	$913.36M	N/A	1,570
YSG Yatsen	0.6446 of 5 stars	$2.60 +3.6%	N/A	-63.8%	$243.88M	$4.54B	N/A	1,623
NUS Nu Skin Enterprises	2.1506 of 5 stars	$4.78 +0.1%	N/A	-53.8%	$232.45M	$1.49B	N/A	2,800	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:WALD) was last updated on 10/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waldencast (WALD) Competitors

WALD vs. PRE, USNA, YSG, NUS, and NATR

How does Waldencast compare to Prenetics Global?

Summary

How does Waldencast compare to USANA Health Sciences?

Summary

How does Waldencast compare to Yatsen?

Summary

How does Waldencast compare to Nu Skin Enterprises?

Summary

How does Waldencast compare to Nature's Sunshine Products?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WALD vs. The Competition

Waldencast Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Waldencast (WALD) Competitors

WALD vs. PRE, USNA, YSG, NUS, and NATR

How does Waldencast compare to Prenetics Global?

Do insiders & institutionals have more ownership in PRE or WALD?

Do analysts recommend PRE or WALD?

Is PRE or WALD more profitable?

Does the media refer more to PRE or WALD?

Which has more risk & volatility, PRE or WALD?

Which has preferable valuation & earnings, PRE or WALD?

Summary

How does Waldencast compare to USANA Health Sciences?

Which has stronger valuation & earnings, USNA or WALD?

Do analysts recommend USNA or WALD?

Does the media refer more to USNA or WALD?

Is USNA or WALD more profitable?

Do institutionals & insiders hold more shares of USNA or WALD?

Which has more risk and volatility, USNA or WALD?

Summary

How does Waldencast compare to Yatsen?

Do analysts recommend WALD or YSG?

Which has more risk & volatility, WALD or YSG?

Does the media prefer WALD or YSG?

Is WALD or YSG more profitable?

Which has preferable valuation and earnings, WALD or YSG?

Do insiders and institutionals believe in WALD or YSG?

Summary

How does Waldencast compare to Nu Skin Enterprises?

Which has stronger valuation & earnings, WALD or NUS?

Which has more risk and volatility, WALD or NUS?

Does the media prefer WALD or NUS?

Is WALD or NUS more profitable?

Do analysts recommend WALD or NUS?

Do institutionals & insiders believe in WALD or NUS?

Summary

How does Waldencast compare to Nature's Sunshine Products?

Do insiders and institutionals have more ownership in WALD or NATR?

Does the media prefer WALD or NATR?

Which has more risk & volatility, WALD or NATR?

Do analysts prefer WALD or NATR?

Is WALD or NATR more profitable?

Which has better earnings & valuation, WALD or NATR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WALD vs. The Competition

Waldencast Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools